Filter
170
Filtered Results: 170
Text search:
pharma
company
Featured
Recommendations
9
New Publications
64
Language
Document type
No document type
74
Studies & Reports
50
Guidelines
20
Manuals
11
Strategic & Response Plan
6
Fact sheets
4
Training Material
2
Situation Updates
2
Resource Platforms
1
Countries / Regions
Global
8
South Africa
8
India
8
Kenya
7
Ethiopia
6
Nigeria
5
Sierra Leone
4
Philippines
4
Western and Central Europe
4
Nepal
3
Uganda
3
Ukraine
2
Ghana
2
Senegal
2
Zimbabwe
2
Mongolia
2
Latin America and the Carribbean
2
Tanzania
2
Eastern Europe
2
China
1
Burkina Faso
1
Malaysia
1
Haiti
1
Germany
1
Argentina
1
Bangladesh
1
Papua New Guinea
1
Namibia
1
Sudan
1
Mali
1
Liberia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
33
Studies & Reports
10
Guidelines
9
Policies
8
Maternal Health
4
HIV & STI
4
Neonatal Care
4
Reproductive Health
4
Pharmacy & Technologies
4
Paediatrics
3
Pediatrics
3
Gynaecology & Obstetrics
3
Laboratory Quality Assurance
3
TB
3
Family Planning
2
Diabetes
2
COVID-19
2
Medical Devices & Equipment
2
Other
2
WASH
2
Surgery & Anaesthesia
2
Primary Health Care
2
Global Health
2
Hepatitis
1
Child Health
1
Community Health
1
Cancer Treatment & Resources
1
Infection Control & Prevention (IPC)
1
Public Health
1
Snakebites
1
Vaccine-preventable Diseases
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Capacity Building
1
Statistics
1
Respiratory Infections
1
Health Systems
1
Women & Child Health
1
NTDs & Others
1
Parasitology
1
Water
1
Age & Elderly
1
Toolboxes
Country specific
8
Reports & Studies
6
Essential Medicines
5
Waste Managment
5
Clinical Aspects, Treatment & Prevention
4
Treatment & Prevention
4
Prices and Patents
4
Quality Assurance
4
Antiretroviral Treatment ART
4
Adults
3
International
3
Falsified & Substandard
3
Pharmacy Practice
3
Supply Chain & Store Management
3
Drug resistant TB
3
Assessment
3
Agriculture & Veterinary
2
Europe
2
Prevention & Control
2
Children & Adolescents
2
Opportunistic Infections
2
Studies
2
General
2
Country Specific
2
Communication Material
2
Fair Allocation & Ethical Aspects
2
Self-care
2
Pharmacy Management
2
Traditional & Herbal Medicines
2
Health Financing Toolbox
2
Human Rights & the Right to Health
2
Research & Access
2
Alcohol
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Children with Disabilities
1
IPC
1
Background PTSD in children
1
Preparedness, Response & Risk Communication
1
Introduction to Global Health
1
Schizophrenia
1
Influenza
1
Stroke
1
Concepts of Global Health
1
Curricula & Core Competencies
1
General Studies & Reports
1
TB
1
Tools for Rational use
1
Advocacy
1
Training
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
Clinical Guidelines
1
Health Personnel
1
Public Health
1
Diagnostics & Laboratory Guidance
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
RCCE Guides & Manuals
1
Access & Strategy
1
Gambling
1
TB/HIV
1
Research & Pipeline
1
Hygiene
1
Primary Care
1
Triage
1
Climate Change General
1
Food environments
1
Model Formulary
1
Resuscitation
1
Epilepsy
1
Antimicrobial Resistance (AMR)
1
Studies & Reports
1
Overview, Studies & Reports
1
Yaws & other Endemic Treponematoses
1
Risk Factors
1
Women
1
Global Overview
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
General
1
Training
1
Tuberculosis
1
Prevention of mother-to-child transmission (PMTCT)
1
Self-harm & Suicide
1
Vision Loss & Blindness
1
General Public
1
TB/HIV Coinfection
1
Tobacco
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Overview & Statistics
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
2nd edition
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Lancet. 2019; 394: 1212-1214
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
